C. Moyes

发表

Field evaluation of the efficacy and immunogenicity of recombinant hepatitis B vaccine without HBIG in newborn Vietnamese infants

D. West, A. Milne, D. V. Chinh, 2002, Journal of medical virology.

Respiratory symptoms and environmental factors in schoolchildren in the Bay of Plenty.

N. Pearce, J. Crane, J. Waldon, 1995, The New Zealand medical journal.

Prevalence of hepatitis B infections in a multiracial New Zealand community.

N. Pearce, A. Milne, C. Moyes, 1985, The New Zealand medical journal.

Risk factors for asthma symptoms in Kawerau children.

N. Pearce, J. Crane, R. Shaw, 1994, The New Zealand medical journal.

Asthma prevalence in European, Maori, and Pacific children in New Zealand: ISAAC study

N. Pearce, E. Mitchell, J. Crane, 2004, Pediatric pulmonology.

Changing patterns in child restraint use.

C. Moyes, J. McLean, R. Tustin, 1984, The New Zealand medical journal.

Hepatitis B vaccination.

C. Moyes, 1994, The New Zealand medical journal.

57 TENOFOVIR DISOPROXIL FUMARATE (TDF) FOR THE TREATMENT OF HBEAG-NEGATIVE CHRONIC HEPATITIS B: WEEK 72 TDF DATA AND WEEK 24 ADEFOVIR DIPIVOXIL SWITCH DATA (STUDY 102)

P. Marcellin, A. Horban, H. Senturk, 2008 .

VERY-LOW-DOSE HEPATITIS B VACCINE IN NEWBORN INFANTS: AN ECONOMIC OPTION FOR CONTROL IN ENDEMIC AREAS

N. Pearce, P. Goldwater, C. Moyes, 1987, The Lancet.

The New Zealand Hepatitis B Screening Programme: screening coverage and prevalence of chronic hepatitis B infection.

C. Bullen, J. Hornell, C. Moyes, 2005, The New Zealand medical journal.

The burden of symptoms of asthma, allergic rhinoconjunctivitis and atopic eczema in children and adolescents in six New Zealand centres: ISAAC Phase One.

N. Pearce, E. Mitchell, J. Crane, 2001, The New Zealand medical journal.

Hepatitis B virus infections.

A. Milne, C. Moyes, G. Allwood, 1985, The New Zealand medical journal.

Genomic Analysis of Hepatitis B Virus Reveals Antigen State and Genotype as Sources of Evolutionary Rate Variation

M. Hurles, P. Lemey, D. Penny, 2011, Viruses.

Liver function and hepatitis markers in carriers of hepatitis B virus in New Zealand.

C. Moyes, C. Lucas, N. Hopkirk, 2000, The New Zealand medical journal.

Liver function of hepatitis B carriers in childhood.

J. Waldon, A. Milne, C. Moyes, 1993, The Pediatric infectious disease journal.

Serological and clinical outcomes of horizontally transmitted chronic hepatitis B infection in New Zealand Māori: results from a 28-year follow-up study

E. Gane, C. Cunningham, B. Borman, 2014, Gut.

Hepatitis B vaccination in children: five year booster study.

N. Pearce, S. Krugman, J. Waldon, 1992, The New Zealand medical journal.

Two percent of patients suspected of having Angelman syndrome have TCF4 mutations

C. Moyes, C. Schwartz, J. Jones, 2010, Clinical genetics.

Chronic hepatitis B infection-an unmet medical need in New Zealand 35 years after universal neonatal vaccination.

E. Gane, C. Cunningham, C. Moyes, 2020, The New Zealand medical journal.

Hepatitis B vaccination in children: Persistence of immunity at 9 years

A. Milne, C. Moyes, N. Hopkirk, 1994, Journal of medical virology.

HBsAg loss in a New Zealand community study with 28-year follow-up: rates, predictors and long-term outcomes

E. Gane, C. Cunningham, B. Borman, 2016, Hepatology International.

SHOULD THE DOSE OF HEPATITIS B VACCINE BE REDUCED IN NEWBORN BABIES?

A. Milne, C. Moyes, 1988, The Lancet.

Hepatitis B carriage in children.

A. Milne, C. Moyes, 1983, The New Zealand medical journal.

A seroepidemiological study of the prevalence of hepatitis B infections in a hyperendemic New Zealand community.

N. Pearce, K. Newell, A. Milne, 1987, International journal of epidemiology.

Serological and clinical outcomes of horizontally transmitted chronic hepatitis B infection in New Zealand Māori: results from a 28-year follow-up study

E. Gane, C. Cunningham, B. Borman, 2014, Gut.